Port Washington, NY, United States of America

Stuart Thomson

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Farmingdale, NY (US) (2013)
  • Port Washington, NY (US) (2011 - 2018)

Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovative Contributions of Stuart Thomson in Cancer Research

Introduction

Stuart Thomson, based in Port Washington, NY, is a distinguished inventor with three innovative patents in the field of cancer research and treatment. His work focuses on the utilization of gene signatures and biomarkers to enhance cancer diagnostics and therapeutic approaches, significantly contributing to advancements in oncology.

Latest Patents

One of his notable patents is titled "Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment." This invention provides diagnostic methods to assess the epithelial to mesenchymal transition (EMT) status of tumor cells, which can predict the effectiveness of cancer treatments, particularly those involving EGFR or IGF-1R kinase inhibitors. Furthermore, the invention entails methods for treating cancer patients by incorporating these diagnostics.

Another significant patent is "Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors." This patent outlines diagnostic and prognostic techniques for predicting a patient's response to EGFR kinase inhibitors by analyzing if tumor cells have undergone EMT. The methodologies developed in this patent also extend to identifying new biomarkers and agents that could restore sensitivity to treatments, which is a major breakthrough in cancer therapy.

Career Highlights

Throughout his career, Stuart Thomson has worked with prominent companies in the biotechnology sector, including Osi Pharmaceuticals, Inc. and Aveo Pharmaceuticals, Inc. His work in these organizations has propelled his research and inventions forward, facilitating the application of his patents in real-world clinical settings.

Collaborations

Stuart has collaborated with noteworthy individuals, including John D. Haley and Julie Kan. These collaborations have allowed him to further refine his innovations and expand the impact of his research findings in the fight against cancer.

Conclusion

In conclusion, Stuart Thomson's contributions to cancer research through his innovative patents illustrate the vital role of inventors in the advancement of medical science. His focus on gene signatures and biomarkers is reshaping the landscape of cancer diagnostics and treatment, providing hope for improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…